J Panos

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Director of Translational Programs

NCTR

Also affiliated: Northwestern University (2013); United States Food and Drug Administration (2014–2021); Western Michigan University (2008–2011); University of Wisconsin–Milwaukee (1997–1999)

11 h-index 45 pubs 415 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

J Panos, Director of Translational Programs at the National Center for Toxicological Research, has a research focus that includes the study of diabetes complications and neurological disorders, such as Alzheimer's disease. Their work has explored the connection between Alzheimer's disease and type 3 diabetes, with a recent publication in 2021 examining this link in African American populations. Panos's scholarship metrics include an h-index of 12, with 58 total publications and 470 total citations. Key collaborators at the National Center for Toxicological Research include Sumit Sarkar and Daniel T. Sloper, with whom Panos has co-authored publications. Panos's recent activity indicates continued engagement in research.

Metrics

h-index: 11
Publications: 45
Citations: 415

Positions

Director of Translational Programs

M-Lifesciences ORCID
Director of Translational Programs publications 2014–2021

National Center for Toxicological Research ORCID
Director of Operations 2016–2018

Spektron Systems ORCID
ORISE Fellow 2012–2016

National Center for Toxicological Research Neurotoxicology ORCID

Selected Publications

Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans (2021)

Metabolic Brain Disease 5 citations DOI OpenAlex
Increased inflammation in BA21 brain tissue from African Americans with Alzheimer’s disease (2019)

Metabolic Brain Disease 18 citations DOI OpenAlex
A Method for Sampling Rat Cerebrospinal Fluid with Minimal Blood Contamination: A Critical Tool for Biomarker Studies (2019)

Neuromethods DOI OpenAlex
Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer’s Disease (2017)

Journal of Alzheimer s Disease 14 citations DOI OpenAlex
P1‐330: Altered Levels of ABETA42 in BA21 Brain Region of African Americans Relative to Caucasians with Alzheimer's Disease (2016)

Alzheimer s & Dementia DOI OpenAlex
Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague–Dawley offspring (2014)

Neurotoxicology and Teratology 15 citations DOI OpenAlex
Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats (2014)

Neurotoxicology and Teratology 4 citations DOI OpenAlex
Developmental methylphenidate (MPH) treatment in rats: Few effects on spatial memory (SM) in the Morris water (MWM) and Barnes mazes (BM) (2013)

Neurotoxicology and Teratology DOI OpenAlex